Pfizer Inc. stock underperformed on Monday compared to its competitors



[ad_1]

Shares of Pfizer Inc. PFE,
-0.29%
fell 0.29% to $ 34.82 on Monday, on what turned out to be a favorable trading session for the stock market, with the S&P 500 SPX Index
+ 0.74%
up 0.74% to 3,915.59 and the Dow Jones Industrial Average DJIA,
+ 0.76%
up 0.76% to 31,385.76. The fall in the stock broke a two-day streak in a row. Pfizer Inc. closed $ 8.26 below its 52-week high ($ 43.08), which the company reached on December 9.

The title showed a mixed performance against some of its rivals on Monday, such as Johnson & Johnson JNJ,
+ 0.29%
increased 0.29% to $ 164.92, Merck & Co. Inc. MRK,
-1.00%
fell 1.00% to $ 75.04, and Novartis AG ADR NVS,
+ 0.52%
rose 0.52% to $ 91.00. Transaction volume (31.5 M) remained 12.5 M below its 50-day average volume of 44.0 M

Editor’s Note: This story was automatically generated by Automated Insights using data from Dow Jones and FactSet. See our terms of use for market data.

[ad_2]

Source link